Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Levistolide A

Levistolide A is an apoptosis inducer and a PEDV virus inhibitor. Levistolide A can induce apoptosis in colon cancer cells and suppress the replication of porcine epidemic diarrhea virus (PEDV) by promoting ROS generation. Levistolide A activates peroxisome proliferator-activated receptor γ (PPARγ) in N2a/APP695swe cells and reduces excessive phosphorylation of tau through the GSK3α/β pathway, improving symptoms in Alzheimer’s mice. Levistolide A improves kidney damage in 5/6 nephrectomy (Nx) mice by inhibiting the RAS, TGF-β1/Smad, and MAPK pathways[1][2][3][4].

Product Specifications

CAS Number

88182-33-6

UNSPSC

12352005

Hazard Statement

H302

Target

Apoptosis; GSK-3; PPAR; Ras; Reactive Oxygen Species (ROS) ; Tau Protein; TGF-β Receptor

Type

Natural Products

Related Pathways

Apoptosis; Cell Cycle/DNA Damage; GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB; PI3K/Akt/mTOR; Stem Cell/Wnt; TGF-beta/Smad; Vitamin D Related/Nuclear Receptor

Applications

Cancer-programmed cell death

Field of Research

Infection; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/levistolide-a.html

Purity

99.34

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(O/C([C@@]1(CC2)[C@]34[H])=C\CCC)C1=C[C@]2([H])[C@]3([H])CCC5=C4C(O/C5=C\CCC)=O

Molecular Formula

C24H28O4

Molecular Weight

380.48

Precautions

H302

References & Citations

[1]Yang Y, et al. Levistolide A Induces Apoptosis via ROS-Mediated ER Stress Pathway in Colon Cancer Cells. Cell Physiol Biochem. 2017;42 (3) :929-938. |[2]Qu X, et al. Levistolide A Attenuates Alzheimer's Pathology Through Activation of the PPARγ Pathway. Neurotherapeutics. 2021 Jan;18 (1) :326-339. |[3]Zeng W, et al. Levistolide A Inhibits PEDV Replication via Inducing ROS Generation. Viruses. 2022 Jan 27;14 (2) :258. |[4]Aobulikasimu N, et al. Levistolide A ameliorates fibrosis in chronic kidney disease via modulating multitarget actions in vitro and in vivo. Life Sci. 2023 May 1;320:121565.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Natural Products

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Tissue FFPE Sections, Joint
CS707210 5x 5 µm

Tissue FFPE Sections, Joint

Sign In for Pricing
View Details
FITC Anti-Human CD64 Antibody[10.1]
E-AB-F1082C-01 20 Tests

FITC Anti-Human CD64 Antibody[10.1]

Sign In for Pricing
View Details
FITC Anti-Human CD64 Antibody[10.1]
E-AB-F1082C-02 100 Tests

FITC Anti-Human CD64 Antibody[10.1]

Sign In for Pricing
View Details
FITC Anti-Human CD64 Antibody[10.1]
E-AB-F1082C-03 2x 100 Tests

FITC Anti-Human CD64 Antibody[10.1]

Sign In for Pricing
View Details
XPNPEP3 Human Gene Knockout Kit (CRISPR)
KN400888 1 Kit

XPNPEP3 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Human ASPHD1 activation kit by CRISPRa
GA116764 1 Kit

Human ASPHD1 activation kit by CRISPRa

Sign In for Pricing
View Details